diabetes mellitus type 2/triglyceride

Веза се чува у привремену меморију

Изаберите тип сортирања

13 резултати

Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new use of Lactobacillus isolates, in particular, to the technical field of treatments for type II diabetes. 2. Description of the Prior Art Diabetes Mellitus is a metabolism disease of many pathogens. It is a

Triglyceride reducing agent

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to triglyceride reducing agents for use in the human body, and, more particularly, a flavour compound for prevention and treatment of hyperlipidemia (hypertriglyceridemia). 2. Description of Related Art The

Compositions and methods for the treatment of metabolic syndrome

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

PRIORITY The present application claims the benefit of Indian Provisional Patent Application No. 1853/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/051596 filed on 28 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into

Carboxyalkylethers, formulations, and treatment of vascular diseases

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

FIELD OF THE INVENTION This invention relates to compounds which are dialkyl ethers having terminal carboxy or tetrazole groups. The compounds are useful for lowering certain plasma lipids in animals, including Lp(a), triglycerides, VLDL-cholesterol, and LDL-cholesterol, and elevating others such as

Carboxyalkylethers, formulations, and treatment of vascular diseases

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Carboxyalkylethers, formulations, and treatment of vascular diseases

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND OF THE INVENTION Vascular diseases such as coronary heart disease, stroke, restenosis, and peripheral vascular disease, remain the leading cause of death and disability throughout the world. About 1.5 million people die each year in the US alone from myocardial infarction resulting from

Carboxyalkylethers, formulations, and treatment of vascular diseases

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2010/008944, filed Dec. 14, 2010, which claims benefit of Korean Patent Application No. 10-2010-0004901, filed Jan. 19, 2010. FIELD OF THE

Trans-clomiphene metabolites and uses thereof

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

FIELD OF THE INVENTION The present invention relates to metabolites of trans-clomiphene in substantially pure form, pharmaceutical compositions comprising same and methods for treating various hormone-dependent disorders. BACKGROUND Clomiphene is a selective estrogen receptor modulator related to

Sulfonamides as GPR40- and GPR120-agonists

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BRIEF DESCRIPTION OF THE INVENTION The present invention relates to compounds that acts as G-protein coupled receptor 120 (GPR120) and/or 40 (GPR40) agonists, pharmaceutical compositions containing them and their use in the treatment of diseases or disorders modulated by said GPRs such as diabetes

Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/007905, filed Dec. 29, 2009, which claims benefit of Korean Patent Application 10-2009-0022937, filed Mar. 18, 2009. TECHNICAL FIELD The

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED ON A COMPACT DISK Not Applicable BACKGROUND OF THE INVENTION In 2003, the International Diabetes Federation estimated that there were 194 million people worldwide with diabetes. Of these, some 16 million

Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Oxidative stress and inflammation are implicated in the pathogenesis of metabolic diseases, diabetes, obesity, dyslipidemia and their associated cardiovascular complications. For example, oxidative stress is a common pathogenic factor leading to insulin resistance, beta-cell dysfunction,

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима